Bavarian Nordic A/S
BAVA
Helyezés a részvények között
#5071
Hellerup, Denmark-based Bavarian Nordic A/S, founded in 1992, specializes in... Hellerup, Denmark-based Bavarian Nordic A/S, founded in 1992, specializes in the research, production, and global distribution of vital, life-saving vaccines. The company's commercialized offerings include non-replicating vaccines for smallpox and monkeypox, marketed as IMVAMUNE, IMVANEX, and JYNNEOS. Additionally, their portfolio features Rabipur/RabAvert for rabies prevention, Encepur for tick-borne encephalitis, and MVABEA, an Ebola vaccine. Bavarian Nordic also maintains a robust pipeline of investigational treatments. This includes MVA-BN (freeze-dried), which has successfully completed Phase III clinical trials for smallpox; MVA-BN RSV, currently in Phase III development for respiratory syncytial virus; ABNCoV2, which completed Phase II trials targeting SARS-CoV-2; and TAEK-VAC, presently in Phase I/II trials for advanced HER2 and brachyury-expressing cancers. The firm engages in key partnerships, notably a license and collaboration agreement with AdaptVac, and licensing agreements with both the National Cancer Institute and the Public Health Service. Bavarian Nordic operates across a wide international footprint, with a presence in countries such as the United States, Germany, Belgium, France, Canada, the United Kingdom, Hong Kong, Saudi Arabia, Australia, Switzerland, and numerous other global markets.
Részvényárfolyam
$36.63
Piaci kapitalizáció
$2.78B
Változás (1 nap)
-0.16%
Változás (1 év)
-1.59%
Ország
DK
Kereskedés Bavarian Nordic A/S (BAVA)
Kategória
Healthcare
Bavarian Nordic A/S (BAVA) részvényárfolyamának története
Legmagasabb napi záróár: $33.72 ekkor: 2026-10-01
Legalacsonyabb napi záróár: $34.65 ekkor: 2003-11-01
Legalacsonyabb napi záróár: $34.65 ekkor: 2003-11-01
Bavarian Nordic A/S részvényárfolyamának története 2003 és 2026 között
Éves részvényárfolyam teljesítmény
| Év | Teljesítmény |
|---|---|
| 2026 (TTM) | 0.41% |
| 2025 | 10.57% |
| 2024 | 8.76% |
| 2023 | -19.61% |
| 2022 | -25.66% |
| 2021 | 40.00% |
| 2020 | 18.69% |
| 2019 | 29.14% |
| 2018 | -47.44% |
| 2017 | 12.36% |
| 2016 | -31.03% |
| 2015 | 60.26% |
| 2014 | 138.27% |
| 2013 | 42.61% |
| 2012 | 26.87% |
| 2011 | -82.59% |
| 2010 | 34.81% |
| 2009 | 16.54% |
| 2008 | -59.42% |
| 2007 | -31.66% |
| 2006 | -0.87% |
| 2005 | -1.44% |
| 2004 | 170.56% |
| 2003 | 0.00% |
Hasonló cégek vagy versenytársak részvényárai
| Vállalat | Részvényár | Változás 1év% | Ország |
|---|---|---|---|
| $536.98 | 25.92% |
US
|
|
| $224.77 | 737.11% |
US
|
|
| $137.83 | -3.78% |
AU
|
|
| $291.76 | 2.51% |
BE
|
|
| $876.75 | 7.69% |
NL
|
